Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Other Working Capital Changes (2010 - 2026)

Vericel (VCEL) posted Other Working Capital Changes of $188000.0 for Q2 2026, down 23.58% sequentially from $246000.0 in Q1 2026, and up 109.68% YoY from $89662.2 in Q2 2025.

Analysis

Vericel (VCEL) Other Working Capital Changes (2010 - 2026) Analysis & Trends

Vericel has reported Other Working Capital Changes for 17 years, with the latest figure at $188000.0 in Q2 2026.

  • Quarterly Other Working Capital Changes rose 109.68% year-over-year to $188000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.6 million (up 1020.98% YoY) and the FY2025 annual result came in at $457000.0, up 5.3% from the prior year.
  • Other Working Capital Changes retreated to -$111000.0 in Q3 2019 per VCEL's latest filing, from $141000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $141000.0 in Q2 2019 and troughed at -$158000.0 in Q2 2018.
  • A 5-year average of $21857.1 and a median of $37000.0 in 2015 frame the typical range for Other Working Capital Changes.
  • The widest YoY moves for Other Working Capital Changes: up 450.57% in 2024, down 366.47% in 2024.
  • Over 5 years, Other Working Capital Changes stood at $51000.0 in 2015, then tumbled by 147.06% to -$24000.0 in 2016, then plunged by 33.33% to -$32000.0 in 2017, then surged by 456.25% to $114000.0 in 2018, then tumbled by 197.37% to -$111000.0 in 2019.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$111000.0, $141000.0, and $46000.0 for Q3 2019, Q2 2019, and Q1 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 188,000.00
Jun 30, 2026 188,000.00
Mar 31, 2026 246,000.00
Mar 31, 2026 246,000.00
Dec 31, 2025 -262,000.00
Dec 31, 2025 -262,000.00
Sep 30, 2025 1.43 Mn
Sep 30, 2025 1.43 Mn
Jun 30, 2025 -1.94 Mn
Jun 30, 2025 -1.94 Mn
Mar 31, 2025 1.23 Mn
Mar 31, 2025 1.23 Mn
Dec 31, 2024 -595,000.00
Dec 31, 2024 -595,000.00
Sep 30, 2024 1.45 Mn
Sep 30, 2024 1.45 Mn
Jun 30, 2024 -1.34 Mn
Jun 30, 2024 -1.34 Mn
Mar 31, 2024 922,000.00
Mar 31, 2024 922,000.00